
Deepika Sarin
Articles
-
Oct 14, 2024 |
analyticalsciencejournals.onlinelibrary.wiley.com | Deepika Sarin |Sunil Kumar |Anurag S. Rathore
Conflicts of Interest The authors declare no conflicts of interest. Supporting Information Filename Description elps8051-sup-0001-SuppMat.docx1.5 MB Supporting Information References 1, , and , “Monoclonal Antibodies: Trends in Therapeutic Success and Commercial Focus,” Drug Discovery Today 28 (2023): 103415. 2, “Posttranslational Modifications and the Immunogenicity of Biotherapeutics,” Journal of Immunology Research 2016 (2016): 5358272.
-
Dec 8, 2023 |
dx.doi.org | Deepika Sarin |Raj Suryanarayanan |Kunal Krishna |M. Reza Nejadnik
Biopharmaceutical products have revolutionized healthcare and have emerged as more effective (than the conventional small molecule-based pharmaceutical products) therapies for management of complex and otherwise difficult to manage diseases, including cancer, arthritis, and autoimmune disorders.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →